Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome

Leukemia

Volumn 10, Issue 3, 1996, Pages 456-459

  Robertson, L E ^a   Plunkett, W ^a   McConnell, K ^a   Keating, M J ^a   McDonnell, T J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Bcl 2; Chronic lymphocytic leukemia

Indexed keywords

ALPHA INTERFERON; CHLORAMBUCIL; CLADRIBINE; CORTICOSTEROID; DNA FRAGMENT; FLUDARABINE; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL DEATH; CELL VIABILITY; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; TRANSCRIPTION REGULATION;

EID: 0029871942     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Yunis JJ. Multiple recurrent genomic defects in follicular lymphoma. New Engl J Med 1987; 316: 79-84.
2. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
3. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ. Bcl-2 immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation Cell 1989; 57: 79-88.
4. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high grade lymphoma in mice transgenic for the t(14;18). Nature 1991; 349: 254-256.
5. Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res 1995; 217: 240-247.
6. Hockenbery D, Zutter M, Mickey W, Nahm M, Korsmeyer SJ. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.
7. Pezzella F, Tse AG, Cordell JL, Pulford KAF, Guter KC, Mason RY. Expression of the Bcl-2 oncogene proteins is not specific for the 14;18 chromosome translocation. Am J Pathol 1990; 137: 225-232
8. Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JL, Kerr JFR. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 1989; 71: 343-348.
9. McConkey DJ, Aguilar-Santelises M, Hartzell P, Prentice RL, Pope JL, Kerr JFR. Induction of DNA cleavage in chronic B-lymphocytic leukemia cells. J Immunol 1991; 146: 1072-1076.
10. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoradenine. Blood 1993; 81: 143-150.
11. Zutter M, Hockenbery D, Silverman GA, Korsmeyer SJ. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 1991; 78: 1062-1068.
12. Moriano MT, Moretti L, Donelli A, Grantini M, Montagni G, Di Prisco AU, Torelli G, Torelli U, Narni F. Bcl-2 gene expression in hematopoietic cell differentiation. Blood 1992; 80: 768-775.
13. Hanada M, Delia D, Aielio A, Stadtmauer E, Reed JC Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820-1828.
14. Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Boldt DH, Kempin SJ, Foon KA. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-Sponsored Working Group. Am J Hematol 152 (abstr.) 1988; 29.
15. Robertson LE, Huh YO, Butler JJ, Pugh WC, Hirsch-Grinsberg C, Stass S, Kantarjian H, Keating MJ. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: Clinical, pathologic, immunophenotypic, and molecular analysis. Blood 1992; 80: 29-36.
16. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-234.
17. Burton K. A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochemistry 1956; 6: 315-323.
18. Begleiter A, Lee K, Israels LG, Mowat MRA, Johnston JB. Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. Blood 1994; 80 (Suppl. 1): 103a.
19. Jewell AP, Worman CP, Giles FJ, Goldstone AH, Lydyard PM. Interferon-alpha induces bcl-2 expression in B-CLL and protects against apoptosis. Blood 1992; 80 (Suppl. 1): 192a.
20. Walton MI, Whysong D, O'Conner PM, Hockenbery D, Korsmeyer SJ, Kohn KW. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 1993; 53: 1953-1961.
21. Miyashita T, Reed JC. Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 1992; 52: 5407-5411.
22. Campos L, Rouault JP, Sabido O, Oriol P, Roubi P, Vasselon C, Archimbaud E, Magaud J, Guyotat G. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091-3096
23. Panayiotidis P, Ganeshaguru K, Foroni L, Jones D, Hoffbrand AV. Long-term culture of CLL cells in bone marrow stromal cells: an in vitro model for CLL. Blood 1994; 84 (Suppl. 1): 456a.
24. Yong K, Reittie JE, Lowdell M, Panayiotidis P, Hoffbrand AV, Jewell AP. Increased survival of chronic lymphocytic leukaemia cultured on bone marrow-derived endothelium. Blood 1994; (Suppl. 1): 460a.
25. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
26. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369: 321-322.
27. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. Bcl-x: a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-609.
28. Mentz F, Blanc C, Michel A, Binet JL, Merle-Beral H. Expression of bcl-2, p53, and c-myc proteins in chronic lymphocytic leukemia: correlation with apoptosis. Blood 1994; 84 (Suppl. 1): 657a.